Samiah Al-Zaidy, MD

Articles by Samiah Al-Zaidy, MD

Samiah Al-Zaidy, MD, on Gene Therapy for Infantile GM1 Gangliosidosis

February 24th 2023

Al-Zaidy, the vice president of clinical development and lead on the GM1 Program at Passage Bio, discussed the results of the phase 1/2 Imagine-01 clinical trial of PBGM01.

Samiah Al-Zaidy, MD

Articles by Samiah Al-Zaidy, MD

Samiah Al-Zaidy, MD, on Gene Therapy for Infantile GM1 Gangliosidosis

Latest Updated Articles

Trending on CGTlive®

Myrtelle’s Canavan Disease Gene Therapy Effects Significant Decrease in CSF NAA and Increases in Brain Myelin Volume

Regeneron’s Gene Therapy DB-OTO Improves Speech Perception in Children With Otoferlin-Related Hearing Loss